English

LXR BIOTECHNOLOGY INC

EDGAR

Quarterly report (10-Q) · filed 1999-11-15

20 filing records in this dataset, filed from 1996-05-09 to 1999-11-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

1999-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-804 thousand USD

1999-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3914221 USD Source
Operating Cash Flow: -3110053 USD Source

Cash and cash equivalents: 898 thousand USD 1999-09-30 Source
Exact value

898392 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-5.59 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Operating cash flow: -9319894 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: -7648738 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -1368297 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -3110053 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -1368297 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -3914221 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -3110053 USD · 1999-01-01 – 1999-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1999-11-15.

Financial data available through: 1998-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 1998-12-31
Operating income: 5 of 11 periods available· newest 1998-12-31
Net income: 5 of 11 periods available· newest 1998-12-31
Operating cash flow: 5 of 11 periods available· newest 1998-12-31
capital expenditure: No compatible figures in this window
Total assets: 4 of 11 periods available· newest 1998-12-31
Total liabilities: 4 of 11 periods available· newest 1998-12-31
Current assets: 4 of 11 periods available· newest 1998-12-31
Current liabilities: 4 of 11 periods available· newest 1998-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 1998-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-80.9%

Prior period

USD 859,013

1997-01-01 – 1997-12-31
Current period

USD 164,038

1998-01-01 – 1998-12-31

Exact inputs and evidence

164038 − 859013 = -694975 USD

859013 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
164038 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · LXR BIOTECHNOLOGY INC · 1998-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Year-over-year change in Revenue: -694975 USD Concept: fundies:Revenue Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 164038 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#2797 Input fundies:Revenue: 859013 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#2797
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 529,705

Prior period

−USD 9.27 million

1997-01-01 – 1997-12-31
Current period

−USD 9.8 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

-9799992 − -9270287 = -529705 USD

-9270287 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-9799992 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · LXR BIOTECHNOLOGY INC · 1998-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Year-over-year change in Net income: -529705 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -9799992 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3069 Input fundies:NetIncome: -9270287 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3069
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 623,386

Prior period

−USD 8.7 million

1997-01-01 – 1997-12-31
Current period

−USD 9.32 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

-9319894 − -8696508 = -623386 USD

-8696508 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-9319894 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · LXR BIOTECHNOLOGY INC · 1998-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Year-over-year change in Operating cash flow: -623386 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -9319894 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3104 Input fundies:OperatingCashFlow: -8696508 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3104
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1998-01-01 – 1998-12-31

Revenue USD 164,038 100% of revenue
Operating costs Derived USD 10.29 million 6,274% of revenue
Operating income −USD 10.13 million −6,174% of revenue
Tax, interest and other Derived −USD 327,755 −200% of revenue
Net income −USD 9.8 million −5,974% of revenue

Cash

Operating cash flow −USD 9.32 million −5,682% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Operating loss: operating costs were 1,984% of revenue.
1997 Operating loss: operating costs were 1,221% of revenue.
1998 Operating loss: operating costs were 6,274% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	0	6021975 Derived	-6021975	-108434 Derived	-5913541	Unavailable	Source 1994-01-01 – 1994-12-31: 0 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -6021975 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -5913541 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -6323170 USD Inspect Operating Cash Flow Open source
1995 1995-01-01 – 1995-12-31	0	6315678 Derived	-6315678	269 Derived	-6315947	Unavailable	Source 1995-01-01 – 1995-12-31: 0 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -6315678 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -6315947 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -5474571 USD Inspect Operating Cash Flow Open source
1996 1996-01-01 – 1996-12-31	414396	8221707 Derived	-7807311	-184312 Derived	-7622999	Unavailable	Source 1996-01-01 – 1996-12-31: 414396 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -7807311 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -7622999 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -5990002 USD Inspect Operating Cash Flow Open source
1997 1997-01-01 – 1997-12-31	859013	10489788 Derived	-9630775	-360488 Derived	-9270287	Unavailable	Source 1997-01-01 – 1997-12-31: 859013 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -9630775 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -9270287 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -8696508 USD Inspect Operating Cash Flow Open source
1998 1998-01-01 – 1998-12-31	164038	10291785 Derived	-10127747	-327755 Derived	-9799992	Unavailable	Source 1998-01-01 – 1998-12-31: 164038 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -10127747 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -9799992 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -9319894 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 164K 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	0	Revenue: 0 Open source
19951995-12-31	Revenue	0	Revenue: 0 Open source
19961996-12-31	Revenue	414396	Revenue: 414396 Open source
19971997-12-31	Revenue	859013	Revenue: 859013 Open source
19981998-12-31	Revenue	164038	Revenue: 164038 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-80.9% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19951995-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19961996-12-31	Year over year	No prior comparable period	Revenue: 414396 Open source Revenue: 0 Open source
19971997-12-31	Year over year	107.3%	Revenue: 859013 Open source Revenue: 414396 Open source
19981998-12-31	Year over year	-80.9%	Revenue: 164038 Open source Revenue: 859013 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6,174% 1998

Net margin -5,974.2% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	Not reported	Operating Income: -6021975 Open source Revenue: 0 Open source
19951995-12-31	Operating margin	Not reported	Operating Income: -6315678 Open source Revenue: 0 Open source
19961996-12-31	Operating margin	-1,884%	Operating Income: -7807311 Open source Revenue: 414396 Open source
19971997-12-31	Operating margin	-1,121.1%	Operating Income: -9630775 Open source Revenue: 859013 Open source
19981998-12-31	Operating margin	-6,174%	Operating Income: -10127747 Open source Revenue: 164038 Open source
19941994-12-31	Net margin	Not reported	Net Income: -5913541 Open source Revenue: 0 Open source
19951995-12-31	Net margin	Not reported	Net Income: -6315947 Open source Revenue: 0 Open source
19961996-12-31	Net margin	-1,839.5%	Net Income: -7622999 Open source Revenue: 414396 Open source
19971997-12-31	Net margin	-1,079.2%	Net Income: -9270287 Open source Revenue: 859013 Open source
19981998-12-31	Net margin	-5,974.2%	Net Income: -9799992 Open source Revenue: 164038 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6323170 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -5474571 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 414396 Open source Operating Cash Flow: -5990002 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 859013 Open source Operating Cash Flow: -8696508 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 164038 Open source Operating Cash Flow: -9319894 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -9.3M 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-6323170	Operating Cash Flow: -6323170 Open source
19951995-12-31	Operating cash flow	-5474571	Operating Cash Flow: -5474571 Open source
19961996-12-31	Operating cash flow	-5990002	Operating Cash Flow: -5990002 Open source
19971997-12-31	Operating cash flow	-8696508	Operating Cash Flow: -8696508 Open source
19981998-12-31	Operating cash flow	-9319894	Operating Cash Flow: -9319894 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	Unavailable	Operating Cash Flow: -6323170 Open source
19951995-12-31	Free cash flow	Unavailable	Operating Cash Flow: -5474571 Open source
19961996-12-31	Free cash flow	Unavailable	Operating Cash Flow: -5990002 Open source
19971997-12-31	Free cash flow	Unavailable	Operating Cash Flow: -8696508 Open source
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: -9319894 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

27.2% 1998

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
19951995-12-31	Liabilities / assets	141.5%	Total Liabilities: 1992448 Open source Total Assets: 1407897 Open source
19961996-12-31	Liabilities / assets	9.4%	Total Liabilities: 1168630 Open source Total Assets: 12418692 Open source
19971997-12-31	Liabilities / assets	17.4%	Total Liabilities: 2356226 Open source Total Assets: 13575099 Open source
19981998-12-31	Liabilities / assets	27.2%	Total Liabilities: 1340365 Open source Total Assets: 4918914 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.25× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	0.16×	Current Assets: 285291 Open source Current Liabilities: 1808908 Open source
19961996-12-31	Current assets / current liabilities	9.96×	Current Assets: 11634284 Open source Current Liabilities: 1168630 Open source
19971997-12-31	Current assets / current liabilities	6.06×	Current Assets: 11787619 Open source Current Liabilities: 1946519 Open source
19981998-12-31	Current assets / current liabilities	3.25×	Current Assets: 3722732 Open source Current Liabilities: 1146906 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 5.91 million Exact value Exact value: -5913541 USD 1994-01-01 – 1994-12-31: -5913541 USD Inspect Net Income Open source Share or cite Citation for Net Income · LXR BIOTECHNOLOGY INC · 1994-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Net Income: -5913541 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5913541 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000891618-98-001277.txt#3043 The citation records this snapshot. The page link may show a newer release later.	−USD 6.32 million Exact value Exact value: -6323170 USD 1994-01-01 – 1994-12-31: -6323170 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LXR BIOTECHNOLOGY INC · 1994-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Operating Cash Flow: -6323170 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6323170 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000891618-98-001277.txt#3080 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 6.32 million Exact value Exact value: -6315947 USD 1995-01-01 – 1995-12-31: -6315947 USD Inspect Net Income Open source Share or cite Citation for Net Income · LXR BIOTECHNOLOGY INC · 1995-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Net Income: -6315947 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6315947 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000891618-98-001961.txt#2891 The citation records this snapshot. The page link may show a newer release later.	−USD 5.47 million Exact value Exact value: -5474571 USD 1995-01-01 – 1995-12-31: -5474571 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LXR BIOTECHNOLOGY INC · 1995-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Operating Cash Flow: -5474571 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5474571 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000891618-98-001961.txt#2921 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 7.62 million Exact value Exact value: -7622999 USD 1996-01-01 – 1996-12-31: -7622999 USD Inspect Net Income Open source Share or cite Citation for Net Income · LXR BIOTECHNOLOGY INC · 1996-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Net Income: -7622999 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7622999 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3069 The citation records this snapshot. The page link may show a newer release later.	−USD 5.99 million Exact value Exact value: -5990002 USD 1996-01-01 – 1996-12-31: -5990002 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LXR BIOTECHNOLOGY INC · 1996-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Operating Cash Flow: -5990002 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5990002 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3104 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	−USD 9.27 million Exact value Exact value: -9270287 USD 1997-01-01 – 1997-12-31: -9270287 USD Inspect Net Income Open source Share or cite Citation for Net Income · LXR BIOTECHNOLOGY INC · 1997-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Net Income: -9270287 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9270287 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3069 The citation records this snapshot. The page link may show a newer release later.	−USD 8.7 million Exact value Exact value: -8696508 USD 1997-01-01 – 1997-12-31: -8696508 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LXR BIOTECHNOLOGY INC · 1997-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Operating Cash Flow: -8696508 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8696508 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3104 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 9.8 million Exact value Exact value: -9799992 USD 1998-01-01 – 1998-12-31: -9799992 USD Inspect Net Income Open source Share or cite Citation for Net Income · LXR BIOTECHNOLOGY INC · 1998-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Net Income: -9799992 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9799992 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3069 The citation records this snapshot. The page link may show a newer release later.	−USD 9.32 million Exact value Exact value: -9319894 USD 1998-01-01 – 1998-12-31: -9319894 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LXR BIOTECHNOLOGY INC · 1998-12-31 LXR BIOTECHNOLOGY INC (edgar:899504) Operating Cash Flow: -9319894 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/899504/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9319894 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/899504/0000950149-99-000562.txt#3104 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000899504, 899504, edgar:899504

LXR BIOTECHNOLOGY INC

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

1998 1998-01-01 – 1998-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation